chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This report describes the occurrence of mercury poisoning in a male child of unspecified age who was vaccinated with hep B vaccine recombinant (Engerix B) for prophylaxis. This report was received as part of litigation proceedings and has not been verified by a physician or other healthcare professional. The subject's medical history, concurrent conditions, and concurrent medications were not reported. The subject received an injection of Engerix B (lot 1722A; not a complete lot number) on 9/14/95. He also received injections of hep B vaccine (manuf unk) 11/14/95 and 9/25/96, Tetramune 11/14/95, 1/18/96, and 4/9/96. Haemophilus influenzae type B conjugate vaccine (manuf unk) 1/28/97, and DTP vaccine (manuf unk) 7/3/97. The subject's attorney alleged that "As a result of the mercury in the Thimerosal-containing vaccinations that the subject received he now suffers, and in the future will continue to suffer, from the toxic neurological effects of mercury poisoning." The attorney further alleged that the subject "has developed severe neurodevelopmental disorders with associated high mercury exposure levels as a result of the vaccinations he received, and has suffered serious permanent injury." Onset and treatment of the events were not specified. The mercury poisoning in this report, with resultant neurodevelopmental disorders, is considered medically serious (OMIC).
IPOL was likely to be used as one dose missing since the excursion with no reported adverse event; temperature excursion as vaccines had multiple short excursions going above 10.3 degrees C, for 50 minutes due to a reason unknown with no reported adverse event; Initial information received on 11-Jul-2023 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves an unknown age and unknown gender patient and reporter reported temperature excursion as vaccine had multiple short excursions going above 10.3 degrees c, for 50 minutes due to a reason unknown with no reported adverse event and  IPV (VERO) [IPOL] was likely to be used as one dose missing since the excursion with no reported adverse event  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Caller reported temperature excursion for open IPOL in JUN-2023 as vaccine had multiple short excursions going above 10.3 degrees c, for 50 minutes due to a reason unknown with no reported adverse event (product storage error) (unknown latency) and the patient received a dose of suspect IPV (VERO) Suspension for injection (lot number, strength, expiry date, dosage- not reported) via unknown route in unknown administration site for Prophylactic vaccination (Immunisation) since the excursion with no reported adverse event (poor quality product administered) (latency- same day)  Information on the batch number was requested  Action taken was not applicable.  At time of reporting, the outcome was Unknown for both the events.   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
bled to the point that the blood was dripping down the arm; This is a spontaneous report received from a contactable pharmacist. A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on an unspecified date at single dose for COVID-19 immunization. Medical history and concomitant medications were not provided. The patient administered vaccine over the weekend, had bled to the point that the blood was dripping down the arm. Outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Patient began to have tenderness of skin around hemodialysis catheter approximately 10/20/13, exudate on 10/26/13, fever 10/27/13 and went to ER. Admitted 10/28/13 on IV antibiotics. Discharged 10/30/13 when blood cultures negative. Study DSMD determined this was not related to vaccination.
NO ADVERSE EVENTS IMMEDIATELY AFTER VACCINE. PATIENT RETURNED STATING HE DEVELOPED A BLOOT CLOT.  HE PRESENTED PAPERWORK STATING TREATMENT FOR A DVT IN HIS ARM AT THE INJECTION SITE.
PATIENT RECEIVED MENINGITIS, HPV, TDAP VACCINATION TODAY.  FOLLOWING VACCINE PATIENT BECAME DIZZY DEVELOPED A HEADACHE.  VITAL SIGNS INCLUDING BP, PULSE, O2 WITHIN NORMAL LIMITS.  SHE WAS LAID FLAT ON EXAMINIATION TABLE, PROVIDED ICE PACK FOR NECK. PATIENT BEGAN TO DEVELOP URTICARIA OF CHEST AND LEFT NECK, NO SWELLING OF THE MOUTH/TONGUE/DIFFICULTY BREATHING.  PT WAS HYDRATED WITH WATER AND PROVIDED A SAMPLE OF CLARITIN 10 MG PO ONCE FOR HIVES.  PATIENT WAS ALSO ADMINISTERED TYLENOL FOR HEADACHE.
The first day, I experienced a very sore arm, like many people, some hours after the event. The next day at work (around 10 am) I felt sleepy and fatigued. However, as noted, I am chronically ill, so I didn't think much of it. I believe that was the day that my faintness/lightheadedness started, but again, I have a lot of symptoms that come and go so I didn't pay it much mind. I also had diarrhea and nausea, but same reasoning. By Saturday I was really noticing the lightheadedness/faintness, especially on standing. I would have to lean for a minute against something on standing and felt like I was going to black out. I was also sleepy and low energy, but had trouble falling asleep. Sunday was bad as well and I had insomnia again, though the diarrhea cleared up by then. Today, Monday, I feel poorly, but I think it is chronic illness poorly and no longer vaccine side effect poorly (I am sleep deprived too). I have only experienced some lightheadedness on standing today and fatigue/sleepiness that may or may not be usual for me. I am putting down that I've recovered because that is my best guess
Flublok inadvertently administered to 17 year old patient, only licensed for 18 and above. No adverse symptoms noted immediately after administration. Parent notified. No additional action taken.
Vaccines were given Dec. 1-2016. By Dec. 2, patient called stating she feels so weak. Nauseous and vomiting a lot, has fever and basically stated the she has the flu.
redness (Started at the spot of injection and then started to go down. It has her hand size this redness); had pain Started at the spot of injection; This spontaneous case was reported by a health care professional and describes the occurrence of VACCINATION SITE ERYTHEMA (redness (Started at the spot of injection and then started to go down. It has her hand size this redness)) and VACCINATION SITE PAIN (had pain Started at the spot of injection) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jan-2021, the patient experienced VACCINATION SITE PAIN (had pain Started at the spot of injection). On 08-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (redness (Started at the spot of injection and then started to go down. It has her hand size this redness)). At the time of the report, VACCINATION SITE ERYTHEMA (redness (Started at the spot of injection and then started to go down. It has her hand size this redness)) and VACCINATION SITE PAIN (had pain Started at the spot of injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment medications were provided by the reporter.
Fever; sore/aches; puffy arm; red puffy arm; This case was reported by a consumer via interactive digital media and described the occurrence of fever in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced fever, pain, swelling arm and erythema of extremities. On an unknown date, the outcome of the fever, pain, swelling arm and erythema of extremities were unknown.   It was unknown if the reporter considered the fever, pain, swelling arm and erythema of extremities to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported, however it was captured as an adult as per vaccine indication. The patient had a routine reaction to dose one of Shingrix as fever, sore, red puffy arm, aches. The reporter questioned what should be expected from dose two.
Adverse effects: fatigue/dizziness/headache,  resolved after 24 hours, left arm pain and swelling around injection site persist for 2-3 days, swelling is continue getting bigger, warm and tender to touch. Tx: possible post-vaccination cellulitis (left arm), given Keflex 500mg tid for 7 days, OTC NSAID prn for pain, swelling edge marked and advised monitor swelling edge, seek immediate care if getting worse, follow up with PCP.
Immediately after given Td pt to c/o dizziness, seizure follow. Arms contracted, upper body rigid for about 20-30 sec. Pale skin, confused. Lost consciousness for about 30 sec. Transported to ER by paramedics. Alert and oriented x2
Initial report received from a healthcare professional on 15 April 2014. A male patient, whose age, medical history and concomitant medications were not reported, had received a dose of PENTACEL, (batch number C4574AA, dose number, route and site of vaccination not reported) on an unspecified date. On an unspecified date, the patient experienced excessive crying. Corrective treatment and laboratory details were not reported. At the time of this report the outcome was unknown. Documents held by sender: none.
Headache, drowsiness, paresthesia of left hand, swelling, pain and redness over the site of the injection on left deltoid with decreased grip strength on left side. Treat with ice and Tylenol.
Chill and fever, temperature 101 F began 1 week after vaccination.  Continued 3 days.  Temperature 102, confused, injection site red, swollen approximately 4" and firm.  Went to ER for evaluation.  States doctor determined symptoms must be due to yellow fever vaccine.  States swelling and redness continued involving upper arm and anterior chest wall.  As of today, (5th day since onset of symptoms), redness and swelling are decreasing, temperature is down 99, and states he is feeling much better.
Awoke at 5am with fever of 101.5; fatigue; tachycardia (HR103-105) at rest, tenderness at injection site.  Took 2000mg acetaminophen to break fever,  Fever broke on Saturday evening.  Slept all day Saturday.
This case was reported by a nurse via call center representative and described the occurrence of injection site swelling in a 55-year-old female patient who received SHINGRIX (batch number 3NY5G, expiry date 7th March 2019) for prophylaxis. On 10th September 2018, the patient received the 2nd dose of SHINGRIX (intramuscular). On 10th September 2018, less than a day after receiving SHINGRIX, the patient experienced injection site swelling (serious criteria clinically significant/intervention required), fever (serious criteria clinically significant/intervention required), facial flushing (serious criteria clinically significant/intervention required), injection site warmth (serious criteria clinically significant/intervention required) and injection site pain. On 13th September 2018, the patient experienced injected limb mobility decreased. The patient was treated with ibuprofen (Motrin), paracetamol (Tylenol), medication unknown (Ice Pack (Nos)) and non-drug therapy (Heating Therapy). On an unknown date, the outcome of the injection site swelling, fever, injection site warmth, injection site pain and injected limb mobility decreased were recovered/resolved and the outcome of the facial flushing was unknown. It was unknown if the reporter considered the injection site swelling, fever, facial flushing, injection site warmth, injection site pain and injected limb mobility decreased to be related to SHINGRIX. Additional details were provided as follows: This case was reported by a nurse practitioner. The patient received dose of SHINGRIX in her left arm. The nurse practitioner reported that her arm hurt following dose 2 of SHINGRIX. By that night she developed a fever of 102, her arm was swollen and hot to the touch. Her face and body were flushed. By the third day, the patient went to the doctor. It hurt to raise her arm up. The patient rotated taking Tylenol and Motrin and cycled with ice and heat and by the fourth day , that night, her symptoms resolved. The patient consented to follow up. The nurse practitioner thought expiration date of vaccine was correct.
Dose 1:  Headache Fatigue, pain at injection site for over 1 week. Hot flash.  Itching at injections side  dose 2: slight fatigue for 5 days now.  Feeling of not being fully awake.   Being very cold and then hot flash for a few hours on night of vaccination.
BP and oxygen all over; 06Apr went to ER been in and out of ICU battling covid/ pneumonia as they say; 06Apr went to ER been in and out of ICU battling covid/ pneumonia as they say; day one normal tenderness at injection site; This is a spontaneous report from a contactable consumer (patient).  A 68-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in Arm Right on 11Mar2021 10:00 (Batch/Lot Number: EN6204) (at the age of 68-years-old) as single dose for Covid-19 immunisation.  Medical history included chronic obstructive pulmonary disease (COPD) and weak immune system. The patient's concomitant medications were not reported. The patient did not receive other vaccine in four weeks. The patient did not have COVID prior to vaccination. The patient underwent nasal swab COVID test on 10feb2021 with negative result, nasal swab rapid PCR COVID test on 15Feb2021 with negative result. On day one (12Mar2021), patient experienced normal tenderness at injection site, by day 3 (14Mar2021), got sick, had daughter call in LEVAQUIN 7 days worth. The patient experienced continuing chest pain from continuous coughing, BP and oxygen all over, over next 2 weeks less physical activity. On 06Apr2021, patient went to ER, had been in and out of ICU battling COVID/ pneumonia as they say. He received plasma from recovered COVID patient and Remdesivir. The patient stayed so isolated in his home; his daughter did all his shopping meds everything. Her family had been tested and was tested several times. The patient stated that he was afraid his COPD and weak immune system couldn't handle the vaccine. The events required a visit to the Doctor or other healthcare professional office/clinic, Emergency room/department or urgent care and led to prolongation of hospitalization (as the vaccine was received during existing hospitalization (as reported)). The events were assessed by the reporter as life-threatening (immediate risk of death from the event). The patient was hospitalized for 21 days. The outcome of the events was unknown.
This spontaneous report as received from a healthcare worker refers to a patient of unknown age and gender. The patient's medical history and concurrent conditions were not provided. On 20-APR-2012 the patient was vaccinated with the first dose of GARDASIL, 0.5 ml, intramuscular, Lot number was not provided. No concomitant medications were reported. The healthcare worker reported that the patient received his first dose of GARDASIL on 20-APR-2012, the second dose on 04-SEP-2013 and the third on 06-NOV-2013. No adverse effects reported. Additional information has been requested.
The Tdap injections were stored in a refrigerator which the temperature gauge malfunctioned. The temp lowered to 10 degrees for unknown amount of time.
Right hand started hurting real bad; Joints are aching like crazy; Can hardly move my fingers; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on specified date at single dose for COVID-19 immunization. Medical history and concomitant medication were not reported. patient had the  COVID Vaccine (later confirmed) this morning at about 08:30. About 3 hours ago, patient right hand started hurting really bad, like joints are aching like crazy. patient can hardly move his/her fingers. It's just in one hand, right hand. patient don't know if it will go away or if she/he need to be concerned about it or what she/he need to do because patient can't move the fingers. It hurts really bad. Patient will see what she/he need to do if she/he just need to take pain medicine or it will go away. Outcome of the events was unknown.   Information about lot/batch number has been requested.
Noticed slight pain, redness + swelling that same evening Dx cellulitis Rx for KEFLEX.
3-4 inch x 3 inch red "hive" (very swollen) red rash on arm. it is very itchy and feels like he got bit by a large mosquito
NOT FEELING WELL; FEEL WEAK; HORRIBLE HEADACHE; This spontaneous report received from a patient via a company representative concerned a male of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the subject experienced not feeling well, feel weak, and horrible headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from not feeling well, feel weak, and horrible headache. This report was non-serious.
After about 12 minutes I asked about the metal taste in my mouth; I began to feel light headed so the EMT took my blood pressure which was 200/100 they did nothing for me except monitor my vitals/My blood pressure remained at that high level; This is a spontaneous report from a contactable consumer. This female consumer report for herself.  A (non-pregnant) female patient with unspecified age received a dose of BNT162B2 (BNT162B2, Formulation: Solution for injection, Lot Number: BNT/ER8733, Expiration date: unknown), via unspecified route, administered in left arm on 26Mar2021 at 13:30 as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Past drug events include Magnesium Sulphate induced Drug hypersensitivity.  On 26Mar2021 01:45 PM, 12 minutes after the vaccination, the patient experienced metallic taste in the mouth. Patient began to feel lightheaded so the EMT took her blood pressure which was 200/100 they did nothing for her except monitored her vitals. After taking her vitals multiple times they sent her home and told her to see her doctor. her blood pressure remained at that high level. she has been monitored her blood pressure since then and her average pressure is 135/75. She has not been able to talk to her doctor yet. The patient lab data includes blood pressure monitoring on an unspecified date with readings of 200/100, 135/75 and a high-level reading with unknown value. The outcome of the events was unknown.  No follow-up attempts possible. No further information expected.
Two days after receiving the vaccine, I started to have a rash next to the injection site; however, two days after that,  my whole upper arm swelled and the rash spread to cover about 1/2 of my upper arm and the rash itself was feverish.
BREATHING WAS HIGHER THAN NORMAL; BODY FELT LITTLE OUT OF CONTROL; DIZZY; MORE LETHARGIC; MORE TIRED; NAUSEA; HEART RATE WAS ELEVATED; ARM PAIN; This spontaneous report received from a patient concerned a 54 year old female. The patient's weight was 202 pounds, and height was 54 inches. The patient's concurrent conditions included alcohol use, and non smoker, and other pre-existing medical conditions included the patient had no known allergies. the patient had no drug abuse or illicit drug usage.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808982, and batch number: 1808982 expiry: UNKNOWN) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. Concomitant medications included ibuprofen for arm pain. On APR-2021, the subject experienced heart rate was elevated. On APR-2021, the subject experienced arm pain. Laboratory data included: Breathing rate increased (NR: not provided) 23 breaths per minute, and Heart rate (NR: not provided) 19 to 54 milliseconds. On 09-APR-2021, the subject experienced dizzy. On 09-APR-2021, the subject experienced body felt little out of control. On 09-APR-2021, the subject experienced more lethargic. On 09-APR-2021, the subject experienced more tired. On 09-APR-2021, the subject experienced nausea. On 10-APR-2021, the subject experienced breathing was higher than normal. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from heart rate was elevated on 13-APR-2021, and breathing was higher than normal on 11-APR-2021, and the outcome of nausea, more lethargic, dizzy, arm pain, body felt little out of control and more tired was not reported. This report was non-serious.; Sender's Comments: V0: Medical Assessment comment was not required as per standard procedure as the case assessed as non-serious.
I woke up the morning after the injection with small welts under my buttocks. Within a day I had swollen lips and large welts all over the upper part of my body. I started on a regimen of prednisone that proved inadequate. Then took a larger dose - cleared up in 2 days.
Began a heavy period on 2/3/21, which is unusual for me. It was a heavy period for about 10 days. I started another period about 2 weeks after that one finished. There was about 3 weeks between that one and my next one. I have an IUD and have not had a true period since having it placed in April 2019. I have no reason to believe that my IUD is out of place, but it will be checked at my next OB appointment next month. I did speak with the OB office over the phone.
Patient said received flu shot on Tues, 8/13 and next day around 1:30pm felt weak, dizzy, sweating, and felt like fainting so his son took him to ER. Next day, thurs, he said he got a big bruise from shoulder to elbow.
Short of breath. Seizures. Pain in chest. Went to hospital ER. As of 7/15/2013 severe joint pain and loss of range of motion in all joints. Can no longer do activities.